Sustainability | May 20, 2022
Pharma companies with ESG more valuable say investors
When asked how to balance ESG with broader business goals, the panel was unanimous in its assessment that ESG is ‘good for business’
When asked how to balance ESG with broader business goals, the panel was unanimous in its assessment that ESG is ‘good for business’
Circular revenues already at 16% of sales, driven by healthcare informatics and services to enhance medical equipment uptime and utilization, system and software upgrades for enhanced functionality and extended lifetime and reusing refurbished parts and systems
The Silver Medal recognizes strong performance across sustainability, ethics, environment, labour & human rights, and responsible procurement
This partnership represents a systemic shift from awareness to large-scale action for 57 lakh children
The program provides pharmaceutical manufacturers with auditable, primary emissions data and verified proof of a 30% CO? reduction across DFE Pharma’s lactose portfolio
Profitability metrics showed a sharper upward trend. Gross margin expanded 280 basis points to 61.2%
Granules India has reported total income of Rs. 1,384.29 crore during the period ended December 31, 2025
WuXi Biologics has integrated sustainability principles throughout its supplier lifecycle management
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
Enabling a new era in minimally invasive obesity treatment across Europe
Subscribe To Our Newsletter & Stay Updated
